Allopurinol may cut diabetes patients' risk of cardiac death

09/5/2013 | Diabetes.co.uk (U.K.) · Scotsman (Edinburgh), The

Type 2 diabetes patients who received the gout medication allopurinol showed reduced thickness of the heart muscle wall compared with those who took a placebo, according to a small study in the Journal of the American College of Cardiology. The findings suggest that while skin reactions are a common side effect, the drug may help reduce cardiac deaths in diabetes patients.

View Full Article in:

Diabetes.co.uk (U.K.) · Scotsman (Edinburgh), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN